Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Gemcitabine × 90 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 35 Carcinoma, Non-Small-Cell Lung 27 Urinary Bladder Neoplasms 26 Lymphoma, Large B-Cell, Diffuse 14 Lung Neoplasms 14 Biliary Tract Neoplasms 13 Ovarian Neoplasms 12 Neoplasm Metastasis 11 Breast Neoplasms 11 Colorectal Neoplasms 9 Carcinoma, Transitional Cell 9 Non-Muscle Invasive Bladder Neoplasms 8 Nasopharyngeal Carcinoma 8 Triple Negative Breast Neoplasms 7 Sarcoma 7 Recurrence 6 Fallopian Tube Neoplasms 6 Cholangiocarcinoma 6 Uterine Cervical Neoplasms 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Neoplasms 5 Lymphoma 5 Hodgkin Disease 5 Gallbladder Neoplasms 5 Carcinoma, Pancreatic Ductal 4 Rectal Neoplasms 3 Osteosarcoma 3 Nasopharyngeal Neoplasms 3 Lymphoma, Non-Hodgkin 3 Gastrointestinal Neoplasms 3

Interventions

Dexamethasone 8 Lenalidomide 7 Bortezomib 5 pomalidomide 3 carfilzomib 3 Calcium Dobesilate 3 Prednisone 2 poly ICLC 1 ibrutinib 1 fludarabine 1 elotuzumab 1 daratumumab 1 citarinostat 1 belantamab mafodotin 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Sirolimus 1 PVX-410 vaccine 1 Mycophenolic Acid 1 Melphalan 1 Granulocyte Colony-Stimulating Factor 1 Everolimus 1 Cyclophosphamide 1 Clonal Hematopoiesis 1 Chromatin Immunoprecipitation Sequencing 1 Blood Cell Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡